B. Vert-), L. Sont, L. Turquoise, G. Est, . En et al., 56 41 FIGURE 12, EN VERT) PAR RAPPORT AU CTV1 (EN TURQUOISE)) .. 42 FIGURE 13: 43 FIGURE 15: PATIENT N°6 (COUPES, p.45

L. G. Johnson, Anal cancer incidence and survival: The Surveillance, Epidemiology, and End Results experience, 1973-2000, Cancer, vol.13, issue.2, pp.281-289, 1973.
DOI : 10.1097/00042560-199804010-00005

URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.20364/pdf

J. R. Daling, Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer, Cancer, vol.61, issue.2, pp.270-80, 2004.
DOI : 10.1097/00042560-199804010-00005

D. P. Ryan, C. C. Compton, and R. J. Mayer, Carcinoma of the Anal Canal, New England Journal of Medicine, vol.342, issue.11, pp.342-792, 2000.
DOI : 10.1056/NEJM200003163421107

R. J. Salmon, Treatment of epidermoid anal canal cancer, The American Journal of Surgery, vol.147, issue.1, pp.43-51, 1984.
DOI : 10.1016/0002-9610(84)90032-1

M. Schlienger, Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases, International Journal of Radiation Oncology*Biology*Physics, vol.17, issue.6, pp.17-1141, 1989.
DOI : 10.1016/0360-3016(89)90519-1

J. A. Ajani, US Intergroup Anal Carcinoma Trial: Tumor Diameter Predicts for Colostomy, Journal of Clinical Oncology, vol.27, issue.7, pp.1116-1137, 2009.
DOI : 10.1200/JCO.2008.19.6857

J. A. Ajani, Prognostic factors derived from a prospective database dictate clinical biology of anal cancer, Cancer, vol.87, issue.17, pp.4007-4020
DOI : 10.1016/j.radonc.2008.04.003

F. Eschwege, Squamous cell carcinoma of the anal canal: treatment by external beam irradiation Epidermoid carcinoma of the anal canal. A series of 276 cases, Radiother Oncol Papillon, J. and J.F. Montbarbon Dis Colon Rectum, vol.3, issue.105, pp.145-50, 1985.

M. P. Pintor, J. M. Northover, and R. J. Nicholls, Squamous cell carcinoma of the anus at one hospital from 1948 to 1984, British Journal of Surgery, vol.48, issue.8, pp.76-806, 1989.
DOI : 10.1007/978-3-642-68613-9

B. M. Boman, Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer Epidermoid cancer of the anorectum, Cancer, vol.54, issue.16, pp.53-1285, 1984.

M. J. Greenall, Treatment of epidermoid carcinoma of the anal canal, Surg Gynecol Obstet, vol.161, issue.6, pp.509-526, 1985.

N. D. Nigro, V. K. Vaitkevicius, B. Considine, . Jr, and N. D. Nigro, Combined therapy for cancer of the anal canal, Diseases of the Colon & Rectum, vol.17, issue.3, pp.354-360, 1974.
DOI : 10.1007/BF02586980

A. Allal, Chemoradiotherapy versus radiotherapy alone for anal cancer: A retrospective comparison, International Journal of Radiation Oncology*Biology*Physics, vol.27, issue.1, pp.59-66, 1991.
DOI : 10.1016/0360-3016(93)90421-Q

H. Bartelink, Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research Chemoradiation for the treatment of epidermoid anal cancer: 13- year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I), J Clin Oncol Lancet Br J Cancer, vol.15, issue.1027, pp.2040-2049, 1996.

M. Flam, Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study., Journal of Clinical Oncology, vol.14, issue.9, pp.14-2527, 1996.
DOI : 10.1200/JCO.1996.14.9.2527

J. A. Ajani, Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal, JAMA, vol.299, issue.16, pp.299-1914, 2008.
DOI : 10.1001/jama.299.16.1914

R. James, A randomised trial of chemoradiation using mitomycin of cisplatin, with or without maintenance cisplatin/5-FU in squamous cell carcinoma of the anus, J Clin Oncol, p.27, 2009.

O. Matzinger, Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014), European Journal of Cancer, vol.45, issue.16, pp.45-2782, 2009.
DOI : 10.1016/j.ejca.2009.06.020

URL : https://hal.archives-ouvertes.fr/hal-00485139

G. Crehange, Combining cisplatin and mitomycin with radiotherapy in anal carcinoma Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness, Dis Colon Rectum J Clin Oncol. Int J Radiat Oncol Biol Phys, vol.50, issue.30164, pp.43-52, 2005.

K. Huang, Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal, World Journal of Gastroenterology, vol.13, issue.6, pp.895-900, 2007.
DOI : 10.3748/wjg.v13.i6.895

J. M. Pepek, C. G. Willett, and B. G. Czito, Radiation Therapy Advances for Treatment of Anal Cancer, Journal of the National Comprehensive Cancer Network, vol.8, issue.1, pp.123-132
DOI : 10.6004/jnccn.2010.0008

A. Konski, Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.1, pp.114-122, 2008.
DOI : 10.1016/j.ijrobp.2007.12.027

M. G. Zampino, K-ras status in squamous cell anal carcinoma (SCC): it???s time for target-oriented treatment?, Cancer Chemotherapy and Pharmacology, vol.50, issue.3, pp.197-206, 2009.
DOI : 10.1016/S1072-7515(01)00967-X

N. Lukan, Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm, Oncology J Clin Oncol, vol.77, issue.357, pp.293-302, 2006.

J. K. Salama, Intensity-modulated radiation therapy in gynecologic malignancies, Current Treatment Options in Oncology, vol.56, issue.2, pp.97-1086, 2004.
DOI : 10.1259/bjr.73.869.10884741

Y. J. Chen, Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.1, pp.274-81, 2005.
DOI : 10.1016/j.ijrobp.2005.05.052

C. Menkarios, Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy, Radiat Oncol Int J Radiat Oncol Biol Phys, vol.82, issue.21, pp.153-161, 2007.

J. K. Salama, Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy for Anal Canal Cancer Patients: A Multicenter Experience, Journal of Clinical Oncology, vol.25, issue.29, pp.25-4581, 2007.
DOI : 10.1200/JCO.2007.12.0170

J. M. Pepek, Intensity-Modulated Radiation Therapy for Anal Malignancies: A Preliminary Toxicity and Disease Outcomes Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.5, pp.1413-1422
DOI : 10.1016/j.ijrobp.2009.09.046

J. G. Bazan, Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal, Cancer, vol.28, issue.15, pp.3342-51
DOI : 10.1200/JCO.2010.29.1351

M. T. Milano, Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.2, pp.354-61, 2005.
DOI : 10.1016/j.ijrobp.2005.02.030

L. K. Mell, Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.66, issue.5, pp.66-1356, 2006.
DOI : 10.1016/j.ijrobp.2006.03.018

C. J. Brixey, Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies, International Journal of Radiation Oncology*Biology*Physics, vol.54, issue.5, pp.1388-96, 2002.
DOI : 10.1016/S0360-3016(02)03801-4

L. K. Mell, Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Anal Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.5, pp.1431-1438, 2008.
DOI : 10.1016/j.ijrobp.2007.08.074

L. A. Kachnic, Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal., Journal of Clinical Oncology, vol.29, issue.4_suppl, p.29, 2011.
DOI : 10.1200/jco.2011.29.4_suppl.368

R. J. Myerson, Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.3, pp.74-824, 2009.
DOI : 10.1016/j.ijrobp.2008.08.070

M. Ng, Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.5, pp.1455-62
DOI : 10.1016/j.ijrobp.2011.12.058

P. Das, Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.3, pp.794-800, 2007.
DOI : 10.1016/j.ijrobp.2006.12.052

J. L. Wright, Squamous Cell Carcinoma of the Anal Canal: Patterns and Predictors of Failure and Implications for Intensity-Modulated Radiation Treatment Planning, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.4, pp.1064-72
DOI : 10.1016/j.ijrobp.2009.09.029

R. Roohipour, Squamous-cell carcinoma of the anal canal: predictors of treatment outcome Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation, Dis Colon Rectum Eur Radiol. Br J Radiol, vol.51, issue.56962, pp.147-53, 2008.

E. Winton, The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer, British Journal of Cancer, vol.140, issue.5, pp.693-700, 2009.
DOI : 10.2214/ajr.140.1.95

J. Sveistrup, Positron Emission Tomography/Computed Tomography in the Staging and Treatment of Anal Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.1, pp.134-175
DOI : 10.1016/j.ijrobp.2011.06.1955

M. Krengli, FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma Assessing the impact of FDG-PET in the management of anal cancer, Radiat Oncol. Radiother Oncol, vol.5, issue.873, pp.376-82, 2008.

S. E. Cotter, FDG-PET/CT in the evaluation of anal carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.3, pp.720-725, 2006.
DOI : 10.1016/j.ijrobp.2006.01.009

R. Graf, Impact of Overall Treatment Time on Local Control of Anal Cancer Treated with Radiochemotherapy, Oncology, vol.65, issue.1, pp.14-22, 2003.
DOI : 10.1159/000071200

E. Ben-josef, The Impact of Overall Treatment Time on Survival and Local Control in Anal Cancer Patients: A Pooled Data Analysis of RTOG Trials 8704 and 9811, Proc ASTRO S5), p.75, 2009.
DOI : 10.1016/j.ijrobp.2009.07.084

S. Janssen, Anal cancer treated with radio-chemotherapy: correlation between length of treatment interruption and outcome, Int J Colorectal Dis, issue.12, pp.24-1421, 2009.

L. Tournier-rangeard, Radiochemotherapy of locally advanced anal canal carcinoma: Prospective assessment of early impact on the quality of life (randomized trial ACCORD 03), Radiotherapy and Oncology, vol.87, issue.3, pp.391-398, 2008.
DOI : 10.1016/j.radonc.2007.12.004

URL : https://hal.archives-ouvertes.fr/hal-00485419

A. Taylor, Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.5, pp.1604-1616, 2005.
DOI : 10.1016/j.ijrobp.2005.05.062

S. Roels, Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer Definition and delineation of the clinical target volume for rectal cancer, Int J Radiat Oncol Biol Phys Int J Radiat Oncol Biol Phys Int J Radiat Oncol Biol Phys, vol.59, issue.704, pp.28-42, 2004.